Crinetics Pharmaceuticals, Inc. (CRNX)
36.96
+0.45
(+1.23%)
USD |
NASDAQ |
Mar 13, 10:01
Crinetics Pharmaceuticals EPS Diluted (Quarterly) : -1.292 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | -0.0412 |
| Madrigal Pharmaceuticals, Inc. | -2.566 |
| GT Biopharma, Inc. | -4.413 |
| Axsome Therapeutics, Inc. | -0.5641 |
| Sutro Biopharma, Inc. | -6.699 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -122.82M |
| Revenue (Quarterly) | 6.161M |
| Total Expenses (Quarterly) | 128.98M |
| Enterprise Value | 2.843B |
| Gross Profit Margin (Quarterly) | 66.40% |
| Profit Margin (Quarterly) | -1.99K% |
| Earnings Yield | -13.38% |
| Normalized Earnings Yield | -13.38 |